No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...
A newly released independent research review is contributing fresh scientific perspective to the ongoing discussion around ...
Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...
The numbers related to opioid dependence and addiction are staggering: More than 10 million people misuse opioids and almost 50,000 people die from opioid overdose every year -- a 519% increase since ...
SEATTLE – September 27, 2024 – Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in ...
Industry sponsors will be required to submit diversity action plans for certain key clinical studies of drugs and devices, according to draft guidance released recently by the US Food and Drug ...
Credit: Getty Images. Worldwide, 2% to 12% of people diagnosed with type 2 diabetes have latent autoimmune diabetes in adulthood (LADA). A 41-year-old Hispanic woman presents to her worksite clinic ...
A recent World Health Organization (WHO) analysis reveals that less than 5% of disease-focused genomic studies are conducted ...
The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, science-forward drug development. By reducing reliance on animal models and ...
Persistent recruitment delays, high dropout rates, and missed timelines continue to slow global clinical trials, while data show that sub-Saharan Africa offers a largely untapped opportunity with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback